Maravai Lifesciences Holdings (MRVI) Inventory (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) recorded quarterly Inventory of $40.5 million in Q1 2026, little changed quarter-over-quarter from $40.5 million in Q4 2025, and down 18.71% on a YoY basis from $49.8 million in Q1 2025.
Maravai Lifesciences Holdings (MRVI) Inventory (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Inventory history runs 7 years deep, the most recent figure standing at $40.5 million for Q1 2026.
- In Q1 2026, Inventory fell 18.71% year-over-year to $40.5 million; the TTM figure through Mar 2026 stood at $40.5 million (down 18.71% YoY), while the FY2025 annual figure was $40.5 million, down 19.14% from the prior year.
- Inventory was $40.5 million for Q1 2026 at Maravai Lifesciences Holdings, roughly flat from $40.5 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $62.4 million in Q3 2022 to a low of $40.5 million in Q1 2026.
- Historically, Inventory has averaged $49.6 million across 5 years, with a median of $49.8 million in 2025.
- The sharpest annual moves came in 2022 and 2023: Inventory increased 25.81% in 2022, then decreased 21.28% in 2023.
- A 5-year view of Inventory shows it stood at $43.2 million in 2022, then grew by 19.11% to $51.4 million in 2023, then fell by 2.56% to $50.1 million in 2024, then fell by 19.14% to $40.5 million in 2025, then dropped by 0.08% to $40.5 million in 2026.
- The last three Inventory figures came in at $40.5 million (Q1 2026), $40.5 million (Q4 2025), and $45.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 32.00 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 1.77 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Maravai Lifesciences Holdings | 747.50 Mn | 739.10 Mn | 33.70 Mn | 40.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.46 Mn |
| Dec 31, 2025 | 40.50 Mn |
| Sep 30, 2025 | 45.33 Mn |
| Jun 30, 2025 | 46.67 Mn |
| Mar 31, 2025 | 49.77 Mn |
| Dec 31, 2024 | 50.08 Mn |
| Sep 30, 2024 | 50.53 Mn |
| Jun 30, 2024 | 49.34 Mn |
| Mar 31, 2024 | 49.85 Mn |
| Dec 31, 2023 | 51.40 Mn |
| Sep 30, 2023 | 49.14 Mn |
| Jun 30, 2023 | 47.40 Mn |
| Mar 31, 2023 | 54.82 Mn |
| Dec 31, 2022 | 43.15 Mn |
| Sep 30, 2022 | 62.42 Mn |
| Jun 30, 2022 | 60.11 Mn |
| Mar 31, 2022 | 51.41 Mn |
| Dec 31, 2021 | 51.56 Mn |
| Sep 30, 2021 | 56.25 Mn |
| Jun 30, 2021 | 47.78 Mn |